Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026
Annovis Bio announced that CEO Maria Maccecchini will present and take partnering meetings at U.S. Biotech Day 2026 (Nov 16-17, Philadelphia) and Pharma Partnering Summit 2026 (Nov 19-20, Boston). Presentations will cover the company's Phase 3 clinical programs for buntanetap, its oral therapy candidate for Alzheimer's and Parkinson's diseases, and upcoming milestones.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.